Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Clinical trial NCT03828201 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03828201
Sponsor: Boston University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Tuberculosis, Multidrug-Resistant

Start date: 2022-06-07
Primary completion: 2027-05-01
Enrollment: 271

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.